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0929-6441/ª 2014, Elsevier Taiwan LLObjective: This studyaims to determinewhether clinical findings andabdominal ultrasound could
be used simultaneously to predict medical resource utilization in patients of acute hepatitis.
Materials andmethods: A retrospective studywith chart reviewwasconducted fromJanuary2003
to June 2007 on all patients admitted to the Emergency Department of the National Taiwan Uni-
versity Hospital, Taipei, Taiwan with a diagnosis of acute hepatitis. Patients with liver cirrhosis
were excluded. Medical resource utilization is defined as the length of hospital stay and the total
medical fee. Analysis of variance, Chi-square test, and t test were adopted in the data analysis.
Results: A total of 117 patients met the inclusion criteria. The ChildePugh score and mild ascites
have positive impacts significant differences ofmedical on both the length of hospital stay and the
total hospital charges. Our results showed a high correlation between the length of hospital stay
and medical costs (rZ 0.762).
Conclusion: The ChildePugh score and sonographic findings can be used to predict medical
resource utilization in patients with acute hepatitis in the emergency department.
ª 2014, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
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ChildePugh Score and Ascites for Acute Hepatitis 89IntroductionTable 1 Demographic and clinical data of 117 patients
with acute hepatitis.
Variables No. of
cases (%)
Sex Female 41 (35)
Male 76 (65)
Age (y) 20e29 23 (20)
30e39 28 (24)
40e49 25 (21)
50e59 27 (23)
60 14 (12)
Etiology Hepatitis B virus 72 (62)
Hepatitis C virus 5 (4)
Drug related 20 (17)
Other cause 20 (17)
ChildePugh score A 55 (47)
B 51 (44)
C 8 (7)
Missing 3 (3)
Sonographic
findings
Ascites 23 (20)
Mild 22 (19)
Moderateesevere 1 (1)
Portal vein dilation 17 (15)
Gallbladder wall thickening 22 (19)
Splenomegaly 22 (19)Liver disease, especially relating to hepatitis virus infec-
tion, is very common in Taiwan. An average of 5100 deaths
occur per year due to chronic liver disease and liver
cirrhosis, listed as one of the top 10 causes of death [1].
The annual number of deaths due to liver disease among
Taiwanese is still on the rise [2].
In 2000, 4,091,000,000 Taiwan dollars were spent on
treating chronic hepatitis and liver cirrhosis. This was the
14th highest medical cost in Taiwan, accounting for 1.7% of
the total medical expense [3]. The most common reasons of
chronic hepatitis are hepatitis B virus (HBV) and hepatitis C
virus (HCV) infections [4].
Because chronic HBV or HCV infection may develop
cirrhosis, liver failure, or hepatocellular carcinoma, most of
the published studies focused on chronic liver disease and
associated medical costs, especially the economics of
antiviral treatment [5,6]. There are limited data regarding
the medical cost and medical source utilization of a patient
with acute hepatitis.
Acute hepatitis is characterized by a sudden elevation of
serum alanine aminotransferase levels. It usually refers to
an abrupt increase in serum alanine aminotransferase to
>5e10 times the upper limit of normal or >3 times the
baseline level [7]. Patients with acute hepatitis were
evaluated on the basis of their blood cell counts,
biochemistry test, coagulation profiles, hepatitis viral
loads, and sonographic findings. The ChildePugh score is a
scoring system used frequently for prognostic prediction in
patients with liver cirrhosis [8]. Whether the ChildePugh
score or current examinations for acute hepatitis can pre-
dict the amount of medical cost spent and the length of
hospital stay (LOHS) for the patient is not clear.
Therefore, the aim of this study is to investigate the
medical cost and LOHS for patients with acute hepatitis and
their relationship with clinical and sonographic findings.
Materials and methods
This retrospective study was conducted from January 2003
to June 2007. Patients who visited the Emergency Depart-
ment (ED) of the National Taiwan University Hospital, Tai-
pei, Taiwan, a teaching medical center, with acute
hepatitis were enrolled. As advanced liver disease was
associated with higher health care costs [5], patients with
liver cirrhosis were excluded from this study. This study was
approved by the hospital Institutional Review Board.
Clinical data, including sex, age, laboratory data, and
etiology of acute hepatitis, were collected by chart review.
Because there are no specific sonographic findings in acute
hepatitis except gallbladder wall thickening [9], sono-
graphic findings, including gallbladder wall thickening,
ascites, portal vein dilation, and splenomegaly, were
collected. The last three findings implied the presence of
portal hypertension. The ChildePugh score was also
calculated based on laboratory data and the presence of
ascites. The etiology of acute hepatitis was based on the
diagnosis by chart recording. Data on medical expenses,
including patient self-payment and National Health Insur-
ance coverage, were collected, starting from when thepatient first visited the ED until the patient was discharged
from the hospital. The LOHS was defined by the start of the
ED visit and the time of discharge from the hospital.
To investigate the relationship between the medical
expense/LOHS and clinical/sonographic findings, all statis-
tical analyses were performed using the SPSS statistical
software, version 18.0 (SPSS Inc., Chicago, IL, USA). Cate-
gorical data were analyzed by Chi-square test or analysis of
variance. Continuous data were analyzed by t test. Pearson
correlation analysis was performed for the LOHS and med-
ical costs. A p value of <0.05 was considered statistically
significant.Results
During this study period, a total of 117 cases were studied.
Table 1 shows the demographic and clinical data of pa-
tients. We did not categorize splenomegaly as mild, mod-
erate, or marked because data were missing in most of the
charts.
Table 2 shows the LOHS according to different variables.
No significant differences exist between the LOHS and sex,
age, and laboratory data. Higher ChildePugh scores and the
presence of splenomegaly were correlated with a longer
LOHS. In the stratification of severity of ascites, patients
with mild ascites were associated with the longest LOHS.
Only one patient with a large amount of ascites died on the
next day after arrival to the ED because of hepatic failure.
The total cost of treatment for the disease is shown in
Table 3. The results showed statistical significance in the
ChildePugh score and presence of ascites relating to the
amount of medical expenditure spent. In the stratification
Table 2 Correlation between length of stay and clinical
variables.
Variables Admission
days
p
Sex Female 12.9  12.1 0.693
Male 11.9  11.9
Age (y) 20e29 8.9  5.4 0.147
30e39 9.7  8.3
40e49 12.7  13.9
50e59 15.8  13.0
60 16.1  17.8
Etiology Hepatitis B 13.1  13.7 0.319
Hepatitis C 13.2  9.0
Drug related 7.8  6.0
Other causes 13.8  9.7
ChildePugh
score
A 8.2  7.1 001
B 16.0  13.8
C 25.3  25.0
Sonographic
findings
Ascites 16.7  16.6 0.068
None 12.2  13.6 0.039
Mild 20.8  19.4
Moderateesevere 1.0  0
Portal vein dilation 11.0  5.6 0.652
Gallbladder wall
thickening
13.6  9.4 0.592
Splenomegaly 17.5  17.1 0.020
Data are presented as mean  SD.
Table 3 Correlation between medical costs and clinical
variables.
Variables Average
costs (NTD)
p
Sex Female 39,899  74,754 0.652
Male 34,662  47,570
Age (y) 20e29 21,753  12,814 0.258
30e39 27,951  35,414
40e49 39,497  64,545
50e59 42,191  39,523
60 63,404  122,815
Etiology Hepatitis B 38,494  65,022 0.563
Hepatitis C 23,840  24,204
Drug related 27,282  16,990
Other causes 33,097  34,642
ChildePugh
score
A 20,976  24,135 0.015
B 52,652  79,347
C 268,505  376,772
Sonographic
findings
Ascites 115,166  239,228 0.029
None 34,969  59,957 0.010
Mild 122,163  249,120
Moderateesevere 21,981  0
Portal vein dilation 29,299  15,797 0.504
Gallbladder wall
thickening
48,813  66,182 0.601
Splenomegaly 55,072  101,108 0.097
Data are presented as mean  SD.
NTD Z new Taiwan dollar.
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associated with the highest medical costs.
Our results showed a high correlation between the LOHS
and medical costs (r Z 0.762).Discussion
Previous studies regarding medical economics in patients
with acute hepatitis were limited. In this study, the results
showed that higher ChildePugh scores were correlated with
a longer LOHS and a higher medical expense. Additionally,
the presence of splenomegaly was positively correlated
with a longer stay, and ascites was positively related to a
higher medical expense.
Reviewing the literature, there are limited data
regarding the use of the ChildePugh score to predict
medical utilization in patients with acute hepatitis. The
ChildePugh score was noted to predict poor prognosis in
patients with cirrhosis [8] or hepatocellular carcinoma [10].
Zhu et al [11] found that the ChildePugh score was an in-
dependent determinant for the LOHS after hepatectomy in
patients with hepatocellular carcinoma. Our study was a
pilot study and was conducted to find out the correlation
between medical utilization and the ChildePugh score. The
ChildePugh score had positive impacts on both the medical
expense and the LOHS. Higher ChildePugh scores were
referred to hepatic decompensation that might be
explained by the higher medical expense the was paid and
LOHS was also longer in these patients [5].
The presence of ascites in sonographic examinations was
correlated positively with medical costs. As portal hyper-
tension developed, formation of collateral vessels and
arterial vasodilation progressed, leading to esophageal
varices or ascites [12]. The presence of ascites in these
patients implied hepatic decompensation [5]. Interestingly,
patients with mild ascites were associated with the highest
medical expense, and not those with a large amount of
ascites. Our results showed a high correlation between the
LOHS and medical costs. The only patient with a large
amount of ascites passed away because of hepatic failure.
Thus, 1-day medical expenditure was calculated. However,
as only a limited number of patients in this study had a
large amount of ascites, the trend of medical expenses
determined based on the severity of ascites cannot be
conclusive.
Moreover, splenomegaly was related to a longer LOHS in
patients with acute hepatitis. The increase in spleen size
may be followed by an increase in the splenic blood flow,
which participates in portal hypertension, actively con-
gesting the portal system [13]. Csikesz et al [14] reported
that the LOHS and total charges per hospitalization
increased with portal hypertension after elective surgery.
Sex and age did not influence the LOHS and medical
expenditures in this study. This result was different from
the statistical data of the Department of Health in Taiwan
that money spent by male patients for viral hepatitis is 2.5
times that spent by female patients in ED visits. Addition-
ally, the older the patient, the more the money spent [15].
However, the definition of cases was different in that we
enrolled the cases with acute hepatitis. In addition, liver
cirrhosis was not included. Moreover, we investigated the
ChildePugh Score and Ascites for Acute Hepatitis 91total medical expense in the ED and during the admission
period.
Furthermore, the etiology of acute hepatitis did not in-
fluence the medical expense and LOHS, even after initi-
ating antiviral treatments. In a recent meta-analysis,
Nucleos(t)ide analogs, such as lamivudine, used frequently
to eradicate HBV were found to have no benefits, in terms
of either improvement in short-term survival or protection
against a rapid progression of the disease to liver failure
[16]. Approximately half of the patients with symptomatic
acute HCV hepatitis resolve their infection spontaneously
within 3e4 months [17]. Treatment is recommended if HCV
RNA remains detectable 3 months after the onset of
symptoms [18]. Therefore, in patients with acute hepatitis,
treatment protocols, mainly supportive care, may be the
same irrespective of different etiologies of hepatitis.
Our study has many limitations. First, this is a retro-
spective study in which some acquired data were not
complete. The relationship between medical expenditure
and other scoring systems such as model for end-stage liver
disease score could not be fully investigated, although the
model for end-stage liver disease score was considered to
be a useful tool for predicting medical expenses associated
with liver transplantation [19]. Second, because the cases
studied were from only one institution, the results of this
study may not be applicable nationwide or to hospitals of
other levels. Third, our study collected data on 117 ED
cases from 2003 to 2007. The number might be limited and
influence the results to extrapolate. Further large-scale or
multicenter studies may be needed for a better under-
standing of the medical expenditure associated with acute
hepatitis in Taiwan. Therefore, authorities may reallocate
medical resources for better management of this common
disease in the country.Conclusion
The ChildePugh score and sonographic findings were
related to the medical cost and LOHS in patients with acute
hepatitis. Our study implies that physicians can use these
frequently used indicators to predict the medical utiliza-
tion. The results may aid in the effective future distribution
of medical resources for the treatment of patients with
liver disease in Taiwan.References
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